United States· US:0169-3105_8b15c5f6-3d6e-4e07-8118-7672c063baaa
Awiqli
A insulin icodec product containing insulin icodec, registered in United States by Novo Nordisk Pharmaceutical Industries, LP. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Insulin icodec is registered in 9 of 19 countries.
Countries holding a registration under ATC A10AE07 (insulin icodec), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Insulin icodec · ATC A10AE07
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INSULIN ICODEC
- Manufacturer
- Novo Nordisk Pharmaceutical Industries, LP
- Country
- United States (US)
- ATC code
- A10AE07
- ATC class
- Insulin icodec
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110169-3105-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin icodec in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAWIQLINovo Nordisk A/S, Bagsvaerd
- BelgiumAwiqli 700 U/mlNovo Nordisk
- SwitzerlandAwiqli FlexTouch 700 E/ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- CanadaAWIQLINOVO NORDISK CANADA INC
- Japanインスリン イコデク（遺伝子組換え）ノボ ノルディスク ファーマ
- ItalyAWIQLI*1 penna preriempita SC 700 U/ml 1,5 ml + 14 aghiNOVO NORDISK A/S
- IcelandAwiqliNovo Nordisk A/S*
- FinlandAwiqliNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Awiqli
- Norway · Awiqli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/914e9168-8f9f-42c7-b2b8-cca3fdc5481d GET /v1/drugs/914e9168-8f9f-42c7-b2b8-cca3fdc5481d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "700",
"substance": "INSULIN ICODEC",
"productndc": "0169-3105",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "U/mL",
"application_number": "BLA761326",
"marketing_category": "BLA"
}See everything about insulin icodec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.